Kekou K., Svingou M., Sofocleous C., Mourtzi N., Nitsa E., Konstantinidis G., Youroukos S., Skiadas K., Katsalouli M., Pons R., Papavasiliou A., Kotsalis C., Pavlou E., Evangeliou A., Katsarou E., Voudris K., Dinopoulos A., Vorgia P., Niotakis G., Diamantopoulos N., Nakou I., Koute V., Vartzelis G., Papadimas G.-K., Papadopoulos C., Tsivgoulis G., Traeger-Synodinos J. (2020)
Background: Promising genetic treatments targeting the molecular defect of severe early-onset genetic conditions are expected to dramatically improve patients' quality of life and disease epidemiology. Spinal Muscular ...